Surgery Partners, Inc. 8-K

What Happened
Surgery Partners, Inc. (SGRY) filed an 8-K on June 5, 2026 reporting the results of its Annual Meeting. As of the record date (April 8, 2026) there were 130,798,102 shares outstanding and entitled to vote. Stockholders re-elected Class II directors Devin O'Reilly, Brent Turner and Laura L. Forese, M.D., approved the advisory (non-binding) vote on executive compensation, and ratified Ernst & Young LLP as the company's independent registered public accounting firm for fiscal year 2026.

Key Details

• Record date: April 8, 2026; outstanding shares entitled to vote: 130,798,102.
• Director election vote totals: Devin O'Reilly — For 90,059,419; Withheld 23,613,725; Broker non-votes 6,243,195. Brent Turner — For 110,147,882; Withheld 3,525,262; Broker non-votes 6,243,195. Laura L. Forese, M.D. — For 91,121,777; Withheld 22,551,367; Broker non-votes 6,243,195. Each will serve until the 2029 annual meeting.
• Advisory vote on executive compensation: For 111,639,092; Against 2,018,777; Abstentions 15,275; Broker non-votes 6,243,195 (approved).
• Auditor ratification: Ernst & Young LLP ratified as independent auditor for fiscal 2026 — For 119,828,741; Against 62,950; Abstentions 24,648.

Why It Matters
These results confirm board continuity (three Class II directors re-elected) and shareholder approval of the company's executive compensation program on a non-binding basis. Ratification of Ernst & Young maintains continuity in external audit oversight for fiscal 2026. Investors may note the presence of broker non-votes (6,243,195) on certain matters, which can affect the total voting mix on non-routine items.